BASF to Exit Two Xinjiang Joint Ventures on Human-Rights Concerns — Update
By Helena Smolak
BASF plans to sell its shares in two joint ventures in China's Xinjiang region, citing allegations against its partner that the German company deemed inconsistent with company values.
The move comes after reports in the German media about human rights abuse of Uyghur people that prompted calls on BASF to exit Xinjiang.
The German chemicals giant said Friday that it doesn't have indications that employees of the two joint ventures, located in Korla, were involved in the alleged human-rights violations.
"Nonetheless, recently published reports related to the joint venture partner contain serious allegations that indicate activities inconsistent with BASF's values," it said.
BASF said the allegations relate to its joint-venture partner, Xinjiang Markor Chemical Industry, in which it doesn't have a stake.
The Chinese company didn't immediately respond to a request for comment outside of business hours in China.
China's Embassy in Germany didn't immediately respond to a request for comment.
The Inter-Parliamentary Alliance on China, a coalition of developed-world lawmakers, urged BASF to withdraw from the region in a letter dated Monday.
BASF said it would accelerate a process to sell its shares in the two joint ventures, BASF Markor Chemical Manufacturing (Xinjiang) and Markor Meiou Chemical (Xinjiang), subject to negotiations and required approvals of the relevant authorities.
BASF said its presence in China remains otherwise unchanged.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
February 09, 2024 09:30 ET (14:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software